Molecular Medicine

Feinstein ‘risk index’ could get the jump on lupus

By GREGORY ZELLER // A complex research effort led by top Feinstein Institute scientists has opened the door to a wide range of early-intervention protocols for the dreaded disease lupus. A Feinstein Institute for Medical Research team led by immunologist and Professor Betty Diamond has developed a system for identifying a person’s risk for lupus by examining antibodies and a specific protein complex found in the blood. Ideally, scientists may use these unique markers to…

Feinstein researchers eye brain-tumor breakthrough

A common medication used to treat parasitic infections could leapfrog to the top of medical science’s brain-cancer arsenal. Pure scientific research funded by federal grants has led to this potential oncological breakthrough by the Feinstein Institute for Medical Research, the research-and-development division of the Northwell Health system. Marc Symons, a professor in the Feinstein Institute’s Karches Center for Oncology Research, is exploring the use of mebendazole – a medication commonly used to treat pinworms –…

Rockefeller researcher nabs Feinstein’s molecular prize

Advanced molecular-genetics studies have earned a Rockefeller University researcher accolades from the Feinstein Institute for Medical Research, and a fat check. While Feinstein Institute scientists are often the ones collecting the research prizes, this time the institute is dishing it out, naming Jeffrey Ravetch – head of the Leonard Wagner Laboratory of Molecular Genetics and Immunology at The Rockefeller University in New York City – the recipient of the fifth-annual Ross Prize in Molecular Medicine….